Summary
A competitive protein binding assay for norethindrone was developed to measure plasma levels in human subjects. The plasma levels were considerably higher in women than in men, especially at low dose levels. The plasma levels were directly related to the dose in men; but greater variations in the plasma levels were observed in women. The plasma half-life was about 5 h in both sexes with single oral doses of 5 to 20 mg. A comparative bioavailability study with norethindrone from 2 different manufacturers, formulated in the same manner, showed no significant differences in absorption characteristics and provided sufficient data for pharmacokinetic analysis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cook, C.E., Karim, A., Forth, J., Wall, M.E., Ranney, R.E., Bressler, R.C.: Ethynodiol diacetate metabolites in human plasma. J. Pharmacol. Exp. Therap.185, 696–702 (1973)
Kishimoto, Y., Kraychy, S., Ranney, R.E., Gantt, C.L.: Metabolism of oral contraceptives I. Metabolism of ethynodiol diacetate in women. Xenobiotica2, 237–252 (1972)
Okuda, H.: Conversion of 3-deoxosteroids to the corresponding 3-ketosteroids in vitro and in vivo, Excerpta Med. Int. Congr. Ser. (Abstract) No. 256, 211 (1972)
Cook, C.E., Twine, M.E., Tallent, C.R., Wall, M.E. Bressler, R.C.: Norethynodrel metabolites in human plasma and urine. J. Pharmacol. Exp. Therap.183, 197–205 (1972)
Kishimoto, Y., Kraychy, S., Ranney, R.E., Zitzewitz, D.J., Gantt, C.L.: Metabolism of oral contraceptives II. Metabolism of norethynodrel in women. Xenobiotica2, 253–258 (1972)
Okerholm, R.A., Peterson, F.E., Keeley, F.J., Smith, T.C., Glazko, A.J.: Competitive protein binding analysis of norethindrone in human plasma and urine (Abstract). J. Steroid Biochem.5, 374 (1974)
MacLaughlin, D.T., Harding, G.B., Westphal, V.: Steroid-protein interactions. XXV. Binding of progesterone and cortisol in pregnancy sera; progesterone-binding globulin and uterine cytosol receptor in the pregnant guinea pig. Amer. J. Anat.135, 179–186 (1972)
Tan, S.Y., Murphy, B.E.P.: Specificity of the progesteronebinding globulin of the guinea pig. Endocrinol.94, 122–127 (1974)
Gerhards, E., Hecker, W., Hitze, H., Nieuweboer, B., Bellman, O.: The metabolism of norethisterone and norgestrel in man. Acta Endocrinol.68, 219–248 (1971)
Cook, C.E., Odiorne, J.J., Dickey, M.C., Twine, M.E., Pellizarri, E.D., Wall, M.E., Bressler, R.C.: Norethindrone plasma levels in human subjects. Life Sci.15, 1621–1629 (1974)
Fotherby, K.: Pharmacokinetics of contraceptive steroids in humans. Proc. Fifth Int. Congr. Pharmacol., San Francisco, California1, 230–239 (1972)
Fotherby, K., Warren, R.J.: Bioavailability of contraceptive steroids from capsules. Contraception14, 261–267 (1976)
Kincl, F.A., Pasqualini, J.R., Hill, J.L.: Norethindrone and ethynyl estradiol plasma levels in humans after oral administration. (Abstract) Sixth Int. Congr. Pharmacol., Helsinki, Finland, July 20–25, 1975
Nygren, K.G., Lindberg, P., Martinsson, K., Bosu, W.T.K., Johansson, E.D.B.: Radioimmunoassay of norethindrone; peripheral plasma levels after oral administration to humans and Rhesus monkeys. Contraception9, 265–278 (1974)
Pasqualini, J.R., Castellet, R., Portois, M.C., Hill, J.L., Kincl, F.A., Cortes-Prieto, J.: Radioimmunoassay of norethindrone-(17 alpha-ethynyl-17 beta-hydroxy-4-estren-3-one) and ethynyl-estradiol (17 alpha-ethynyl-1,3,5,(10)-estratrien-3,-17 beta-diol). Application to human plasma determination of norethindrone after oral administration of this steroid. Reproduction2, 197–205 (1975)
Stillwell, W.G., Stillwell, R.N., Horning, E.C.: Analysis of nanogram quantities of norethisterone in plasma using a GC-MS-COM selective ion detection procedure. Steroids Lipids Res.5, 79–90 (1974)
Verma, P., Curry, C., Ahluwalia, B.: A radioimmunoassay for norethindrone. II. Plasma levels in hypertensive and normotensive oral contraceptive users. Anal. Lett.9, 91–103 (1976)
Warren, R.J., Fotherby, K.: Radioimmunoassay of synthetic progestins, norethisterone and norgestrel. J. Endocrinol.62, 605–618 (1974)
Kulkarni, B.D.: Steroid contraceptives in non-human primates (I). Metabolic fate of synthetic estrogens in the baboon before exposure to oral contraceptives. Contraception14, 611–623 (1976)
Mills, T.M., Lin, T.J., Hernandez-Ayup, S., Greenblatt, R.B., Ellegood, J.O., Mahesh, V.B.: The metabolic clearance rate and urinary excretion of oral contraceptive drugs I. Norethindrone. Amer. J. Obstet. Gynecol.120, 764–772 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okerholm, R.A., Peterson, F.E., Keeley, F.J. et al. Bioavailability of norethindrone in human subjects. Eur J Clin Pharmacol 13, 35–39 (1978). https://doi.org/10.1007/BF00606680
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606680